Classmate discussion response

Older Population Healthcare Dynamics Response

I agree with your observations and sentiments regarding how that older populations'
healthcare dynamics have improved over time. The improvement is commendable, as many
elderly Americans are bound to positively benefit from the same. Both Medicare A and B parts
carry essential financial benefits that can help elderly people who cannot fully and comfortably
fund healthcare services still be able to access essential healthcare facilities (Chao et al., 2022).
Essentially, Medicare part A and B can help facilitate financial aid for patients in need of both
inpatient and outpatient healthcare services. In this regard, elderly Americans can still be able to
afford healthcare services without worries regarding the element of cost.
However, it is important to note the challenges the initiative has encountered. Elderly
people are still bound to face healthcare cost difficulties if the challenges are not fully and well
addressed. Primarily, the initiative has faced challenges associated with financial uncertainties
and payment reductions in the wake of the Covid19 pandemic (Padula et al., 2021). As a result,
diverse healthcare facilitators have hesitated to admit new Medicare patients. Therefore, patients,
especially elderly ones, may likely face cost-related challenges when attempting to access
healthcare services under the Medicare program. The development means that the government
ought to go back to the drawing board and find ways of streamlining the program once again.

References

Chao, G. F., Chhabra, K. R., Yang, J., Thumma, J. R., Arterburn, D. E., Ryan, A. M., ... &
Dimick, J. B. (2022). Bariatric surgery in Medicare patients: examining safety and
healthcare utilization in the disabled and elderly. Annals of surgery, 276(1), 133-
139.https://doi.org/10.1097/SLA.0000000000004526
Padula, W. V., Malaviya, S., Reid, N. M., Cohen, B. G., Chingcuanco, F., Ballreich, J., ... &
Alexander, G. C. (2021). Economic value of vaccines to address the COVID-19
pandemic: a US cost-effectiveness and budget impact analysis. Journal of medical
economics, 24(1), 1060-1069.https://doi.org/10.1080/13696998.2021.1965732